| Symbol | NASC |
|---|---|
| Name | NASCENT PHARMA HOLDINGS INC. |
| Sector | UNDEFINED |
| Region | North America |
| Industry | - |
| Address | 11801 United States NY 960 South Broadway Suite 118 |
| Telephone | +1 5165959544 |
| Fax | — |
| — | |
| Website | https://nascentpharmaholdings.com |
| Incorporation | US |
| Incorporated On | 2005 |
| Employees | — |
| Fiscal Year | 12/31 |
| Public Since | — |
| Exchanges | OTC |
| Auditor | Haynie & Company, CPA; |
| Audit Status | UNAUDITED |
| Reporting Status | Alternative Reporting Standard |
| CIK | 0002042814 |
| Description | Our patent portfolio held by Can B Corp. in its Nascent Pharma, LLC Division includes three issued patents with claims to popular cannabis and hemp-based products and manufacturing methods that dominate the cannabis, hemp and CBD industry. The Can B patents were tested in an earlier litigation, survived, and now benefit from several favorable court rulings. The targeted industry includes the major cannabis industry leaders and supports a substantial damage model. The monetization project discussed below justifies the significant investment necessary for success. Additional info from OTC: Additional info from OTC: |
No news found.